- US-listed companies
- Iterum Therapeutics plc
- Balance sheet
Iterum Therapeutics plc (ITRMF) Balance sheet
Market cap
$488K
P/E ratio
| 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | 45 | 5 | 15 | 27 | 21 | 6 | 24 |
| Marketable securities, current | 40 | - | - | 54 | 40 | 18 | - |
| Total cash & short-term investments | 85 | 5 | 15 | 81 | 61 | 24 | 24 |
| Total current assets | 93 | 12 | 21 | 83 | 62 | 26 | 25 |
| Property, plant and equipment, net | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Total non-current assets | 5 | 14 | 11 | 8 | 4 | 1 | 20 |
| Total assets | 98 | 26 | 33 | 92 | 67 | 26 | 45 |
| Accounts payable | 4 | 15 | 1 | 1 | 3 | 5 | 0 |
| Long-term debt, current | 1 | 6 | 6 | 2 | - | - | - |
| Total current liabilities | 12 | 37 | 42 | 13 | 9 | 14 | 18 |
| Long-term debt, non-current | 13 | 8 | 22 | 7 | 10 | 11 | - |
| Total non-current liabilities | 14 | 15 | 42 | 28 | 30 | 19 | 31 |
| Total liabilities | 26 | 52 | 83 | 41 | 39 | 33 | 49 |
| Common stock and paid-in capital | 0 | 0 | 0 | 0 | 0 | 0 | 482 |
| Retained earnings | -132 | -235 | -287 | -378 | -423 | -461 | -486 |
| Stockholders' equity | 72 | -26 | -51 | 50 | 28 | -6 | -4 |
| Total debt | 14 | 13 | 29 | 9 | 10 | 11 | - |
| Net debt | -70 | 9 | 14 | -73 | -51 | -12 | - |
| D/E ratio (%) | 19.7 | -51.2 | -57 | 17 | 36.1 | -178.9 | - |